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Arteriovenous (AV) malformation (AVM) is a devastating condition
characterized by focal lesions of enlarged, tangled vessels that
shunt blood from arteries directly to veins. AVMs can form
anywhere in the body and can cause debilitating ischemia and
life-threatening hemorrhagic stroke. The mechanisms that un-
derlie AVM formation remain poorly understood. Here, we exam-
ined the cellular and hemodynamic changes at the earliest stages of
brain AVM formation by time-lapse two-photon imaging through
cranial windows of mice expressing constitutively active Notch4
(Notch4*). AVMs arose from enlargement of preexisting microves-
sels with capillary diameter and blood flow and no smooth muscle
cell coverage. AV shunting began promptly after Notch4* expres-
sion in endothelial cells (ECs), accompanied by increased individual
EC areas, rather than increased EC number or proliferation. Alter-
ations in Notch signaling in ECs of all vessels, but not arteries alone,
affected AVM formation, suggesting that Notch functions in the
microvasculature and/or veins to induce AVM. Increased Notch sig-
naling interfered with the normal biological control of hemodynam-
ics, permitting a positive feedback loop of increasing blood flow and
vessel diameter and driving focal AVM growth from AV connections
with higher blood velocity at the expense of adjacent AV connec-
tions with lower velocity. Endothelial expression of constitutively
active Notch1 also led to brain AVMs in mice. Our data shed light on
cellular and hemodynamic mechanisms underlying AVM pathogen-
esis elicited by increased Notch signaling in the endothelium.
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Proper vascular perfusion requires a capillary interface be-tween arteries and veins. Establishing and preserving the
arteriovenous (AV) interface are critical for tissue function. AV
malformation (AVM) is a pathological perturbation of the AV in-
terface and is characterized by enlarged, tangled vessels that shunt
blood directly from arteries to veins lacking intervening capillaries
(1). Brain AVMs can cause ischemia, intracerebral hemorrhage,
disability, stroke, and death. About half are first diagnosed between
20 and 40 y of age (1), accounting for 50% of childhood stroke (2).
The developmental mechanisms of AVM pathogenesis remain
poorly understood, hindering the development of therapeutic
treatment strategies.
Clinical evidence has led to two theories about the origin of
brain AVM. First, brain AVMs are congenital and caused by failed
regression of embryonic AV connections that persist into postnatal
life (3). This theory is based on morphological interpretation of
AVMs that resemble primitive vascular structures. However, the
lack of detection by prenatal ultrasonography suggests that AVMs
are either too small to detect in fetal stages or they develop after
birth. The second theory suggests that AVMs result from improper
remodeling of venules (4). Examination of biopsies from skin tel-
angiectases in humans suggests that enlargement of postcapillary
venules precedes AVM formation and can occur in postnatal life
(5). However, the critical precipitating event remains unknown.
Loss-of-function mutations identified in the familial disease He-
reditary Hemorrhagic Telangectasia (HHT), including the TGF-β
family receptor Alk1 (HHT2) (6) and its coreceptor endoglin
(HHT1) (7), have provided valuable models to study the molecular
basis of AVMs. Genetic deletion of each of these genes has
revealed that they are required for normal vascular development
and prevention of AVM formation (6–8). Mutations in SMAD4,
RASA1, and PTEN have also been linked to AVMs in humans (9,
10), and mutations in Rasa1 lead to AV shunting in zebrafish (11).
The Notch receptors are transmembrane proteins that promote
arterial endothelial cell (EC) specification by enhancing expres-
sion of arterial molecular markers and suppressing the expression
of venous markers (12–19). Abnormal signaling induces enlarged
AV connections and shunting in mouse and zebrafish embryos
(12–14). Notch activity is aberrantly increased in the endothelium
of human brain AVMs (18, 20), suggesting that it may participate
in the growth or maintenance of human AVMs. These findings
offer exciting opportunities to understand the molecular mecha-
nisms of AVM formation. We have previously reported a mouse
model, Tie2-tTA;TRE-Notch4* or Tie2-Notch4* mice, wherein
postnatal expression of constitutively active Notch4 (Notch4*) in
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ECs results in spontaneous AVMs in mice (15–17, 21). Although
this work has facilitated new research directions regarding the
Notch pathway in AVMs, how aberrant Notch signaling leads to
AVM remains unknown. Elucidating the initiating structural
events that lead to AV shunt formation would provide insight
into AVM pathogenesis.
A major obstacle to understanding AVM pathogenesis has been
the inability to observe AVM formation and blood flow over time
with high-resolution in vivo imaging. Here, we examined AVM
formation in Tie2-Notch4* mice from the initial genetic event,
illuminating disease progression using “5D” two-photon imaging,
which allows high-resolution live imaging of vascular architecture
(3D) and blood velocity (the fourth dimension) over time (the fifth
dimension) (16, 22, 23). Our findings provide insights into the
mechanism of brain AVM formation.
Results
Notch4*-Mediated AV Shunts Arise from the Enlargement of
Capillary-Like Vessels. To determine the developmental origin
of AVMs, we performed longitudinal live imaging in the brains of
Tie2-Notch4* mice, in which Notch4* expression was repressed
until birth by tetracycline treatment. We implanted cranial windows
over the right parietal cortex of mice at postnatal day 7 (P7) and
used in vivo two-photon microscopy to record vessel diameter
and blood velocity over time. We measured lumen diameters of
vessels connecting arteries and veins, or AV connections, at their
narrowest point. We defined measurements ≥12.5 μm as AV
shunts because AV connections of this diameter were not ob-
served in control mice after P12 (SI Appendix, Fig. S1). We found
that AV shunts developed from capillary-like vessels in Tie2-
Notch4* mice beginning at ∼P12 (Fig. 1 and SI Appendix, Figs. S2
and S3). Of 109 of the AV connections that we tracked, 41 (38%)
grew to ≥12.5 μm between P14 and P25 in 12 mutants, and 4 of
109 (4%) grew to ≥30 μm (Fig. 1A and Movies S1 and S2).
However, the initial diameter did not differ from that of controls
(5.4 ± 1.6 vs. 5.3 ± 1.6 μm, Fig. 1B). We saw no correlation be-
tween the final and initial diameters of AV shunts (SI Appendix,
Fig. S4). We conclude that AV shunts in Tie2-Notch4* mice
enlarge from capillary-diameter AV connections, but that only a
few continue to grow into large AVMs.
We examined the hemodynamics of AV shunts at their onset
and as they enlarged. Using 5D two-photon imaging (16, 23),
we simultaneously analyzed red blood cell velocity and AV
connection diameter (Fig. 1 C–E and SI Appendix, Fig. S2). AV
Fig. 1. Tie2-tTA;TRE-Notch4* mice developed AV shunts through enlargement of capillary-like vessels. (A and A′) Two-photon time-lapse imaging of FITC-
dextran–labeled AV connections in the cerebral cortex through a cranial window. An AV shunt (red arrowheads and green arrows) developing from
a capillary-diameter AV connection between P14 and P19. (B) Distribution of initial AV connection diameter (smallest lumen diameter) in AV connections in
mutants (109 AV connections in 12 mice) and controls (36 AV connections in 5 mice, ages P8–P11). (C and D) Blood velocities (dotted lines) and lumen
diameters (solid lines) measured over time in the capillary-like AV connections of (C1–C3) Notch4*mice and (D) controls. (E) Time of initial velocity increase vs.
time of initial diameter increase for individual AV connections. Dotted red line represents simultaneous increase of blood velocity and vessel diameter. Points
on the dotted vertical black line represent capillary-like vessels that enlarged but did not exhibit a significant increase in velocity. Increased velocity and
diameter were defined by changes >2× the SD in control capillaries: 0.82 mm/s for velocity and 1.33 μm for diameter. (F and G) Whole-mount immunostaining
of P12 surface cerebral cortex vasculature for α-smooth muscle actin (green) and VE-cadherin (red) in mutant (F) and control (G). Arrowheads indicate AV
shunt (18 AV shunts in seven mice); corresponding lectin perfused vessels are shown (F′ and G′). (Scale bars, 50 μm.)
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connection enlargement either coincided with or preceded the
initial increase in velocity (Fig. 1C1, 8/18 vessels in four mice).
Some capillary-like vessels enlarged without a significant increase
in velocity (Fig. 1C2, 4/18 vessels in four mice), whereas others
exhibited an increase in neither diameter nor velocity (Fig. 1C3,
6/18 vessels in four mice). Neither velocity nor diameter increased
in controls (Fig. 1D, 18 vessels in four mice). Data are summarized
in Fig. 1E. Thus, our data suggest that blood velocity in AV con-
nections that grew into AV shunts is initially capillary-like and
becomes abnormally elevated only when connections enlarge.
As capillaries lack smooth muscle cell (SMC) coverage, we
performed staining for α-smooth muscle actin (SMA) at P12,
when AV shunts were first apparent. We identified 10 AV shunts
from five mice that lacked SMA staining (Fig. 1F). In contrast,
adjacent arteries were positive for SMA staining, similar to con-
trols (Fig. 1G and SI Appendix, Fig. S5). We observed, as we have
previously published (15–17), that advanced AVMs exhibited in-
creased SMA staining. Thus, the absence of SMCs in the initial
AV shunts is consistent with a capillary origin of AVMs in the
Tie2-Notch4* mice.
We next examined the expression of Notch4* during the initi-
ation of AV shunting. We previously demonstrated that Tie2-tTA
effectively and specifically drives gene expression throughout the
brain endothelium, through activation of the tetracycline re-
sponsive element (TRE) by the tetracycline transactivator (tTA)
(17). Here we performed whole-mount staining of brain vascula-
ture for the Notch4 intracellular domain (ICD), which also detects
Notch4*, without the extracellular domain. We detected elevated
Notch4-ICD throughout vasculature (reflecting Notch4* expres-
sion) in the mutants over the controls (SI Appendix, Fig. S6).
To examine the kinetics of Notch4* expression in real time
during AV shunt formation, we analyzed TRE-H2b-eGFP; Tie2-
tTA; TRE-Notch4* mice. TRE-H2b-eGFP reports tTA activity and
thus TRE-Notch4* expression. As expected, there was a positive
correlation between H2b-eGFP intensity and Notch4* expression
in fixed samples, validating the reporter assay (SI Appendix, Fig.
S7). We found that tTA activity preceded, by about 2 d, the en-
largement in each segment (branch point to branch point) of the
AV connections measured (Fig. 2 A–C). Approximately 80% (159/
198) of segments were positive for the TRE-H2b-eGFP reporter
(Fig. 2D and SI Appendix, Fig. S8). About 50% (83/159) of the
positive segments enlarged, and 40% (59/159) of these became
part of AV shunts ≥12.5 μm in diameter. Only 15% (24/159)
regressed (Fig. 2D and SI Appendix, Fig. S8). In contrast, only 10%
of the H2b-eGFP–negative segments enlarged (4/39); 80% (31/39)
regressed. These data suggest that Notch4* expression promptly
leads to AV shunting.
EC Area, but Not Number or Proliferation, Increased in AV Shunt
Formation. To examine the cellular changes underlying the initi-
ation of AV shunts, we used the R26R-confetti reporter (24) to
track the position and number of labeled cells. We activated the
reporter from P1 to P5 by tamoxifen (TAM) induction of Cdh5
(PAC)-CreERT2 in Tie2-tTA;TRE-Notch4*; Cdh5(PAC)-CreERT2;
R26R-Confetti mice and littermate controls (with either TRE-
Notch4* or Tie2-tTA, but not both), allowing the tracking of ECs
during AV shunt formation (Fig. 3A). Surprisingly, we saw no
detectable increase in cell number in the initial 48 h of AV shunt
formation (Fig. 3 A and B and SI Appendix, Fig. S9), despite
a two- to threefold increase in AV shunt diameter (Fig. 3B).
Because our analysis was powered to detect as little as a twofold
difference in cell number, these data suggest that AV shunt
growth does not occur through a simple increase in EC number.
To investigate whether cell proliferation is involved in the initiation
of AV shunts, we performed BrdU analysis of tomato-lectin–labeled
ECs. This assay showed no significant difference in the number
of BrdU+ ECs (labeled for 48 h leading up to the analysis, Fig.
3 C and D and SI Appendix, Fig. S10). Furthermore, we found no
BrdU+ EC cells in 10/15 AV shunts with diameters ≥12.5 μm,
again suggesting that the initiation of the AV shunt does not
require increased EC proliferation.
We hypothesized that a change in the area covered by individual
ECs might support the capillary enlargement in Tie2-Notch4*
mice. To test this, we stained whole-mount cortical sections of
mutants and controls for vascular endothelial cadherin (VE-cad-
herin, Cdh5) during the initial stages of AV shunt formation (P12).
We found that the area covered by individual ECs increased more
than threefold during the early stages of AV shunt formation (Fig.
3 E and F, mean cell area of 157 ± 24 μm2 in three Tie2-tTA mice
and 540 ± 46 μm2 in five Tie2-tTA;TRE-Notch4* mice with AV
shunts ≥12.5 μm; P = 0.0001 by two-tailed Student t test). Thus, an
increase in EC area correlates with the enlargement of capillaries
in AV shunt formation.
Notch4* Expression in ECs of Arteries Was Not Sufficient to Induce AV
Shunt Formation.We asked where in the vascular tree Notch4* acts
to elicit AV shunt formation. Our in vivo imaging suggested that
a defect in the capillaries or microcirculation led to AV shunts.
Because no capillary EC-specific tTA driver has been reported, we
used Cdh5(PAC)-CreERT2 to induce Notch4* in all ECs and
a recently developed arterial-specific line, BMX(PAC)-CreERT2,
to examine the effects of Notch4* specifically in the arterial ECs.
We first confirmed the expression of the two inducible Cre
lines in our system. Cdh5(PAC)-CreERT2 efficiently activated
a mT/mG Cre-reporter throughout the vascular endothelium,
but not in circulating blood cells (SI Appendix, Figs. S11 and
S12). The ROSA:LNL:tTA system effectively induced Notch4*
expression, resulting in even higher protein levels than Tie2-tTA–
driven expression (SI Appendix, Fig. S13 and Movie S3) (25). As
demonstrated in other tissues (26), BMX(PAC)-CreERT2 effi-
ciently activated the same reporter throughout the arterial trunk
Fig. 2. Notch4 expression increased in brain capillaries before enlargement
of AV shunts. (A and A′) Two-photon imaging of an AV connection from P11
to P16; Texas-Red–dextran labels plasma (red) and TRE-H2b-eGFP indicates
tTA activity (green). (B1–B4) Diameter vs. number of GFP+ cells in vessel
segments: increased (B1 and B2), stable (B3), and decreased (B4) diameter.
(C) Correlation between time of initial detection of GFP+ cells and initial
diameter increase in capillary-diameter vessel segments of Notch4* mice.
Gray regions indicate that GFP+ cells were not detected or diameter increase
was not detected or both. Dotted line represents simultaneous detection of
GFP+ cells and diameter increase. The “×” indicates the means. GFP was
detected before (125/198 vessel segments, five mice), or simultaneous with
enlargement (19/198) in most cases. (D) Percentage of vessel segments (TRE-
eGFP+ or negative) that demonstrated an increase, decrease, or no change in
diameter or that completely regressed. Increased or decreased diameter is
defined by >2× the SD of change in control vessels (1.1 μm) in the same period;
segments are defined by branch points. (Scale bars: A, 100 μm; C, 50 μm.)
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in the brain vasculature (SI Appendix, Fig. S11). Examination of
mice with combined expression of the arterial marker ephrin-B2-
H2b-eGFP and BMX(PAC)-CreERT2;mT/mG revealed that BMX
(PAC)-CreERT2 excision overlapped with ephrin-B2-H2b-eGFP
in arteries but not in microvessels (SI Appendix, Fig. S14 and
Movie S3). Therefore, BMX(PAC)-CreERT2 was uniformly active
in arteries but not small arterioles. As such, the Cdh5(PAC)-
CreERT2; ROSA:LNL:tTA driver induces Notch4* expression
throughout the vascular endothelium, similar to the Tie2-tTA sys-
tem, whereas the BMX(PAC)-CreERT2; ROSA:LNL:tTA driver
induces Notch4* specifically in the endothelium of arteries.
To evaluate the formation of AV shunts, we examined tomato-
lectin–perfused whole-mount preparations of Cdh5(PAC)-
CreERT2; ROSA:LNL:tTA;TRE-Notch4* and BMX-CreERT2;
ROSA:LNL:tTA;TRE-Notch4* at P18, when most Tie2-Notch4*
mice have developed AV shunts (17). As expected, we readily
detected enlarged AV connections in Cdh5(PAC)-CreERT2; ROSA:
LNL:tTA ;TRE-Notch4* mice by P18 after TAM injection at
P7–P8 to induce Cre-mediated tTA expression (Fig. 4A and SI
Appendix, Table S1). In these mice, 82.8 ± 21.8% of total AV
connections were enlarged. By contrast, the BMX-CreERT2;ROSA:
LNL:tTA;TRE-Notch4* mice resembled the negative littermate
controls with only 2.1 ± 3.6% of total AV connections enlarged
(Fig. 4 B and C and SI Appendix, Table S1). Therefore, expression
of Notch4* in the endothelium of BMX-CreERT2 positive arter-
ies is not sufficient to induce AV shunts in the brain.
Rbpj in the ECs of BMX-CreERT2–Negative, but Not BMX-CreERT2–
Positive Arteries, Was Required for Notch4*-Induced AV Shunt
Formation. To investigate the molecular mediator of Notch4*-
induced AV shunt formation, we examined Rbpj, a transcription
factor required for canonical Notch signaling. We deleted Rbpj
in Tie2-tTA;TRE-Notch4*;Cdh5(PAC)-CreERT2;Rbpjf/f mice be-
fore the onset of AV shunts by injecting TAM at P7–P8. Excision
of Rbpj using Cdh5(PAC)-CreERT2 effectively suppressed AV
shunt formation, and only 1.2 ± 1.7% of total AV connections
were enlarged by P18 (Fig. 4D and SI Appendix, Table S2). In
contrast, in controls with one remaining Rbpj allele, 22.3 ±
17.2% of total AV connections were enlarged (Fig. 4E and SI
Appendix, Table S2). Thus, Notch4*-induced AV shunts require
canonical Notch signaling via Rbpj.
Because AV shunts were Rbpj-dependent, we tested whether
blocking arterial Notch signaling suppresses AV shunt forma-
tion. We deleted Rbpj by injecting TAM at P7–P8 in arterial ECs
of Tie2-tTA;TRE-Notch4*; BMX(PAC)-CreERT2;Rbpj f/f mice.
Excision of both Rbpj alleles using BMX(PAC)-CreERT2 did not
suppress the AV shunt phenotype, because we found that 62.7 ±
27.5% of total AV connections were enlarged by P18 (Fig. 4F
and SI Appendix, Table S2), which is no different from mice with
excision of only one Rbpj allele [60.1 ± 36.4% of total AV
connections enlarged (SI Appendix, Table S2)]. Taken together,
these data suggest that the onset of AV shunts is mediated
through Rbpj in the ECs of microvasculature and veins but not
BMX(PAC)-CreERT2–positive arteries.
AV Shunts with Higher Velocity Increased in Velocity and Diameter,
Whereas Adjacent Vessels with Lower Velocity Decreased in Velocity
and Diameter. Despite Notch4* expression throughout the vas-
cular endothelium, not all AV connections developed into AV
shunts, and not all AV shunts continued to enlarge. We
Fig. 3. Endothelial growth in the AV shunt accompanied by the expansion of
endothelial cell surface area. (A) Two-photon time-lapse imaging showing Cdh5
(PAC)-CreER; Confetti-marked nuclear GFP+ and cytoplasmic YFP+ ECs in cere-
bral cortex of mutants and controls. Texas-Red–dextran labels plasma. (B)
Quantification of total cell number and AV connection diameter over the same
interval (22 AV connections in five mutants, 11 AV connections in three con-
trols). (C) Whole-mount BrdU staining/lectin perfusion. P12 AV connection from
mutant cerebral cortex is shown. Blue dots indicate Hoechst+/lectin+ cells.
White dots indicate BrdU+/lectin+ cells. (D) Quantification of BrdU+ ECs, total
ECs, and AV connection diameter (34 connections in controls, 20 AV connections
<12.5 μm in five mutants, and 15 AV connections ≥12.5 μm in four mutants).
Gray indicates all Hoechst+/lectin+ cells, and the colored portion indicates the
number of BrdU+/lectin+ cells. (E) Whole-mount staining of P12 cerebral cortex
for VE-cadherin, counterstained by lectin perfusion. (F) Correlation of size of
VE-cadherin–traced cells in P12 control (blue) and Notch4* (red) connections
with AV connection diameter (24 AV connections in 11 mutants, 6 AV con-
nections in three controls). (Scale bars: A, 100 μm; C and E, 25 μm.)
Fig. 4. Changes in Notch signaling in the artery alone did not affect AV
shunt formation. (A–F) Lectin-perfused vasculature on P18 surface cerebral
cortex. (A and B) ROSA:LNL:tTA;Notch4* mice in which Notch4* was ex-
pressed at P7 with temporally inducible Cre-recombinase. (D–F ) Notch4*
mutant or control mice with Cre-mediated RBPJ deletion at P7. (A) n = 83 AV
connections in three mice. (B) n = 43 AV connections in three mice. (C) n = 103
AV connections in three mice. (D) n = 191 AV connections in five mice. (E)
n = 186 AV connections in six mice. (F) n = 171 AV connections in seven mice.
Blue arrowheads indicate AV connections. (Scale bars, 100 μm.)
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investigated whether differences in blood flow velocity determine
the growth of AV shunts. We identified arterial branch points in
mutant mice in which one branch clearly led into an AV shunt (V1
in Fig. 5 A and B). We measured velocity and diameter in the
higher-velocity AV shunt and the lower-velocity adjacent artery
(V2 in Fig. 5 A and B) over time in Tie2-Notch4* mice and
compared the changes in velocity and diameter to control arteries
(V1 and V2 in Fig. 5 C and D). The velocities in control arteries
were more stable, varying by an average of 16% between time
points vs. 45% in the mutants. In five of seven cases where the
velocity in the AV shunt increased, the velocity in the adjacent
artery with lower velocity decreased [compare Fig. 5 A to B;
see summary in Fig. 5E “when AV shunt velocity increases”
(see example in Movie S4)]. In three cases, the velocity was
reduced in both the AV shunt and its adjacent artery (Fig. 5E,
“when AV shunt velocity decreases”). The velocity in control
arteries did not change (Fig. 5E, “control”). Thus, increased
velocity in AV shunts is often accompanied by decreased ve-
locity in the adjacent arteries of Tie2-Notch4* mice.
We then investigated whether changes in velocity correlated
with changes in diameter in Tie2-Notch4* mutants. We focused
on the AV shunts in which velocity increased and adjacent
arteries in which velocity decreased (represented by red dots in
Fig. 5E). We found that the adjacent downstream arteries indeed
regressed, compared with either the AV shunt or arteries mea-
sured in control mice (Fig. 5F, P < 0.02 by two-tailed Student
t test, V2 in Fig. 5 A and B, and SI Appendix, Fig. S15). There-
fore, changes in velocity correlated with changes in diameter, so
that the highest velocity connections, which also tended to be
the most proximal AV connections in the Tie2-Notch4* mice,
exhibited increasing velocity and diameter, whereas the lower
velocity and typically distal arterial branches exhibited reduced
velocity and diameter.
For a broader perspective on AV shunt progression, we ex-
amined the whole brain by casting the vessels with radio-opaque
microfil and imaging with microCT. Despite widespread AV
shunting in mutant mice, AVM development appeared focal
(Fig. 5G). Thus, our data suggest that the unchecked growth
of higher-velocity AV connections results in focal AVM
development.
Endothelial Expression of Activated Notch1 Induced AV Shunt Formation.
To determine whether expression of constitutively active Notch1
in the endothelium also causes AV shunt formation, we com-
bined a constitutively active, tTA-responsive Notch1* allele (16)
with Tie2-tTA and activated Notch1* at birth. Five of five Tie2-
tTA;TRE-Notch1* mice exhibited signs of ataxia or lethargy by
P14, as well as large brain AVMs, whereas none of six controls
were affected (Fig. 6). Thus, endothelial expression of constitu-
tively active Notch1 induces brain AV shunts during neonatal
development.
Discussion
Here, we provide novel mechanistic insights into AVM forma-
tion. Our data suggest that AV shunts arise from the enlarge-
ment of capillary-like vessels and that cell-autonomous Notch
signaling in the endothelium of microvasculature and veins is
sufficient and required for AVM formation. AV shunt initiation
is accompanied by the enlargement of EC area but not increased
proliferation. Blood flow mediates AV shunt progression by
positive feedback of increasing flow and increasing diameter,
leading to the selective growth of focal AVMs.
Our data shed light on the origin of AVMs. The vascular
structure of brain AVMs has led to speculations that they arise
from failed regression of primitive AV connections during de-
velopment (3, 4). Extrapolation of histological analysis of skin
AVMs led others to propose that brain AVMs arise from the
dilation of postcapillary venules (5). In contrast to the existing
models, our results demonstrate that Notch4*-induced AV shunts
grow from preexisting capillary-like connections with no detect-
able differences from normal capillaries in either their diameter or
their velocity. This suggests a new, potentially capillary-originated
model of AVM initiation.
Endothelial but not hematopoietic Notch signaling is critical in
the formation of AV shunts. Previous work has demonstrated a
critical function for blood cells in separating the blood and lym-
phatic vascular systems (27). Our data, confirmed by two in-
dependent induction systems, demonstrate that increased Notch
signaling specifically within the endothelium is sufficient to cause
AV shunt formation without obvious involvement of the blood
cells. Conversely, expression of Notch4* specifically in Scl-tTA–
positive blood lineages did not lead to AV shunt formation (SI
Appendix, Fig. S16). Furthermore, no increase in CD45+ cells was
observed near AV shunts (SI Appendix, Fig. S17). Together, our
data suggest that expression of Notch4* in the blood lineages is
insufficient to induce AV shunts and that endothelial Notch4*
elicits AVMs in a cell-autonomous fashion.
Initial enlargement of AV shunts correlates with area expan-
sion of individual ECs, rather than increased proliferation. Con-
sistent with this finding, we found that the converse is true: EC
area is reduced during AV shunt regression upon turning off the
Fig. 5. AV shunts with higher velocity enlarged whereas adjacent arteries
with lower velocity reduced in caliber. (A–D) Two-photon time-lapse imag-
ing of FITC-dextran–labeled blood vessels on cerebral cortex through a cra-
nial window. Average blood velocity, as determined by line-scan analysis of
single RBCs is indicated for the AV shunt (V1) and the adjacent artery (V2) in
a mutant (A and B) and control (C and D). (E) Change in velocity over 24–48 h
in distal arteries from Notch4* AV shunts when shunt velocity increased (n =
7) or decreased (n = 3), and in the smaller artery of similar branch points in
controls (n = 5). (F) Change in diameter of AV shunts and adjacent arteries in
the subgroup of Notch4* mice in which AV shunt velocity increased and
distal velocity decreased (red points in E). (G and H) MicroCT of microfil-
labeled whole-brain vasculature in (G) Notch4* and (H) control mice. Arrow
indicates focal aggregation of enlarged arteries and veins. *P < 0.05. (Scale
bars, 100 μm.)
Fig. 6. Endothelial expression of Notch1-ICD induced AV shunts. Lectin-
perfused vasculature of P14 (A) Tie2-tTA; TRE-Notch1* mutant and (B)
littermate control. (Scale bar, 100 μm.)
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Notch4* transgene (16). Further investigation is required to de-
termine whether an altered cell area is a direct or indirect effect of
Notch4*. Whether further enlargement of AV shunts beyond the
initial stage depends on cell proliferation is currently unknown.
We speculate that the growth of the AV shunts eventually requires
cell proliferation because AV shunts in symptomatic mice can be
>10-fold larger than normal capillaries.
Notch signaling in the microvasculature and veins is both
sufficient and required for AVM formation. Arterial BMX(PAC)-
CreERT2–mediated up- or down-regulation of Notch signaling
could not induce or suppress AV shunt formation, respectively.
In the same genetic systems, global endothelial Cdh5(PAC)-
CreERT2–mediated up- or down-regulation could. These findings
are consistent with recent work showing that Rbpj-mediated
arterial Notch signaling is dispensable for postnatal artery for-
mation in the retina (26). Together, these data show that changes
in Notch signaling in the BMX(PAC)-CreERT2 active cells are
not critical in AV shunt formation, implying that it induces AVM
through effects on the microvasculature and veins.
Blood flow is a key regulator of vessel caliber (28). Based on
clinical studies, it has been proposed that increased flow through
low-resistance AV shunts encourages their growth while “steal-
ing” blood flow from adjacent higher-resistance vessels (29).
However, previous studies have typically focused on a single time
point with lower resolution than we show here. We provide ex-
perimental evidence that endothelial Notch4* permits a “steal”
and perpetuates a positive feedback loop, leading to selective
growth of higher-velocity connections at the expense of lower-
velocity connections.
Our data also demonstrate that, in controls, blood velocity in
adjacent two-branch arteries is maintained at a comparable rate
over time. In mutants, the blood velocity in adjacent two-branch
arteries varies greatly and with increasing disparity. Our earlier
work shows that turning off Notch4* expression normalizes high-
velocity AV shunts by rapidly reducing the flow and diameter of
the AV shunt while increasing flow and diameter to the distal
artery (16). Together, these findings suggest that sustained en-
dothelial expression of Notch4* compromises biological checks
that prevent AV connections from enlarging and “stealing” flow
from adjacent vessels.
We believe that normal AV specification is critical in main-
taining proper hemodynamics in the vasculature. Because Notch
signaling is a critical determinant of AV specification, it is con-
ceivable that either gain or loss of Notch activity could disrupt
AV specification, compromising normal vascular control of he-
modynamic forces and leading to AVMs. Indeed, both gain- and
loss-of-function Notch mutants develop abnormal shunting in
mouse embryos (13, 30). Our model is consistent with recent
work hinting that reduced Notch signaling in HHT type 2 could
contribute to AVMs (31). We propose that increased Notch
signaling in the endothelium of nonarterial vessels disturbs bi-
ological control of blood flow by allowing the persistent growth
of high-flow AV connections at the expense of lower flow AV
connections (SI Appendix, Fig. S18).
Materials and Methods
See SI Appendix for detailed information on materials and methods. Cranial
windows, in vivo imaging, lectin-perfusion, Notch4-ICD, SMA, and VE-cadherin
immunostaining was as we described (16). BrdU immunostaining was as
described (32). For peripheral blood isolation, blood was removed from right
ventricles, and erythrocytes were lysed. Flow cytometry was performed fol-
lowing CD45 immunostaining and DAPI labeling. For MicroCT, images of
Microfil-labeled vasculature were acquired using a μCT 40 system (Scanco
Medical AG). All mouse lines used have been published. This study was
carried out in strict accordance with National Institute of Health regulations
and the Institutional Animal Care and Use Committee at the University of
California, San Francisco.
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